HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B-Reference-Cited by-同舟云学术

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B

Published:2008-01-07 Issue:2 Volume:47 Page:428-434
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fried Michael W.,Piratvisuth Teerha,Lau George K. K.,Marcellin Patrick,Chow Wan-Cheng,Cooksley Graham,Luo Kang-Xian,Paik Seung Woon,Liaw Yun-Fan,Button Peter,Popescu Matei

Publisher

Wiley

Subject

Hepatology

Reference45 articles.

1. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature;Mommeja-Marin;HEPATOLOGY,2003

2. Treatment of chronic hepatitis B: case selection and duration of therapy;Leung;J Gastroenterol Hepatol,2002

3. Nucleoside analogs as anti-HBV agents;Zhou;Curr Top Med Chem,2006

4. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B;Fattovich;HEPATOLOGY,1986

5. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B;Niederau;N Engl J Med,1996

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of HBeAg decline rate from mid‐pregnancy to delivery with HBeAg seroconversion after delivery in hepatitis B virus‐infected mothers;Journal of Viral Hepatitis;2024-05-10

2. A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues;Annals of Hepatology;2024-01

3. Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma;Frontiers in Oncology;2023-07-13

4. Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon‐alfa;Journal of Viral Hepatitis;2023-01-06

5. Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate;F1000Research;2022-12-15